Ease of travel, interconnected financial markets, and differences in testing & response have upped the collateral damage from this latest coronavirus.
The Kidney Project is bringing new hope to patients with end stage renal disease.
New therapies are beginning to come online to change outcomes for kidney disease patients.
Following successful preclinical trials and FDA funding, Cumberland Pharmaceuticals is preparing to launch a new Phase II trial of ifetroban to treat cardiomyopathy in Duchenne Muscular Dystrophy patients.
From transplants to trials, Nashville hospitals are leading the way in cardiac care.
VUMC's Harvey Murff, MD, stays busy training providers, dispelling myths about geriatric care.
A joint project between Vanderbilt and Ole Miss was one of eight selected by the American Medical Association to reimagine residency programming.
When it comes to rolling out new systems, Neal Patel, MD, said listening to users and understanding concerns are critical to success.
Noted public health expert Dr. William Schaffner shares insights on three of his top public health threats.
Researchers at Vanderbilt University Medical Center (VUMC) are participating in a national effort to develop vaccines and other treatments as countermeasures to prevent the spread of two emerging and deadly viruses -- Nipah and Hendra.
Now in its ninth year, the March of Dimes Nurse of the Year Awards recently celebrated 17 outstanding professionals who embody leadership, compassion and excellence.
Dr. Ashish Shah is the driving force behind the growth and innovation at one of the nation's busiest heart transplant programs.
On June 5, representatives from the American Medical Association's Accelerating Change in Medical Education (ACE) leadership team visited Vanderbilt University School of Medicine (VUSM) to review accomplishments made during the past five years of VUSM's participation in the ACE consortium.
In April, Vanderbilt University Medical Center announced the launch of a wholly owned subsidiary to advance drug and diagnostic discoveries.
Nashville Medical News is honored to serve as media sponsor for the annual March of Dimes Nurse of the Year Awards. We salute the winners and all the nominees for their dedication in caring for our community.
Vanderbilt has become the first in Tennessee to perform next gen knee surgery with an implant containing the patient's own regrown cartilage cells.
A multi-institutional team of researchers has found a new antiviral drug candidate that could treat or prevent a number of potential pandemic outbreaks.
Vanderbilt University Medical Center and the March of Dimes, with the support of the Tennessee Department of Health and UnitedHealth Group, are working together to offer a new model of group prenatal care called Supportive Pregnancy Care® (SPC) to area women and babies.
New multicenter research, which included Vanderbilt University Medical Center investigators, could change treatment approaches to simple skin abscesses, infections often caused by Staphylococcus aureus (staph) bacteria.
The sooner you know, the sooner you can act - advances in RNA diagnostics are helping providers identify disease more rapidly and move to the treatment phase.
Vanderbilt University Medical Center (VUMC) cancer researcher James Goldenring, MD, PhD, has received a two-year, $200,000 grant from the DeGregorio Family Foundation in Pleasantville, New York, to begin clinical trials of a potential approach for reversing precancerous stomach lesions.
Vanderbilt University Medical Center (VUMC) is one of four centers receiving a $15 million, four-year research award from the American Heart Association to provide cutting-edge research on obesity as part of its sixth Strategically Focused Research Network (SFRN).
New report finds even a small amount of coronary artery calcium in those under age 50 is a big predictor of increased risk for coronary heart disease.
Dentists, dental hygienists, pediatricians, family practitioners and other primary care providers play an important role in the early detection of oral cavity cancers, and ... equally importantly ... in fostering prevention by providing education on key risk factors.
After a decade of work, Vanderbilt scientists have received the green light to take a novel drug to the next step in humans.
President & CEO
Vanderbilt University Medical Center
Vanderbilt University School of Medicine
November 3-4 • Hilton Garden Inn
Friday, Oct. 21
Strategies for acute stroke management have changed considerably in the past two years, including two new devices for removing clots and five new studies on interventional management of stroke in 2015. Come learn about these innovations and more.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: